Global Basal Insulin (Long-Acting Insulin) Market Research Report 2023

Global Basal Insulin (Long-Acting Insulin) Market Research Report 2023

Table of Contents
1 Basal Insulin (Long-Acting Insulin) Market Overview
1.1 Product Overview and Scope of Basal Insulin (Long-Acting Insulin)
1.2 Basal Insulin (Long-Acting Insulin) Segment by Type
1.2.1 Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Type (2023-2029)
1.2.2 Lantus
1.2.3 Levemir
1.2.4 Tresiba
1.2.5 Toujeo
1.2.6 Basaglar
1.2.7 Biosimilar Glargines
1.3 Basal Insulin (Long-Acting Insulin) Segment by Application
1.3.1 Global Basal Insulin (Long-Acting Insulin) Market Value by Application: (2023-2029)
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Basal Insulin (Long-Acting Insulin) Market Size Estimates and Forecasts
1.4.1 Global Basal Insulin (Long-Acting Insulin) Revenue 2018-2029
1.4.2 Global Basal Insulin (Long-Acting Insulin) Sales 2018-2029
1.4.3 Global Basal Insulin (Long-Acting Insulin) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Basal Insulin (Long-Acting Insulin) Market Competition by Manufacturers
2.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Basal Insulin (Long-Acting Insulin) Average Price by Manufacturers (2018-2023)
2.4 Global Basal Insulin (Long-Acting Insulin) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Product Type & Application
2.7 Basal Insulin (Long-Acting Insulin) Market Competitive Situation and Trends
2.7.1 Basal Insulin (Long-Acting Insulin) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Basal Insulin (Long-Acting Insulin) Players Market Share by Revenue
2.7.3 Global Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Basal Insulin (Long-Acting Insulin) Retrospective Market Scenario by Region
3.1 Global Basal Insulin (Long-Acting Insulin) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Basal Insulin (Long-Acting Insulin) Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2018-2029
3.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2018-2023
3.2.2 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2024-2029
3.3 Global Basal Insulin (Long-Acting Insulin) Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2018-2029
3.3.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2018-2023
3.3.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2024-2029
3.4 North America Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.4.1 North America Basal Insulin (Long-Acting Insulin) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2029)
3.4.3 North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.5.1 Europe Basal Insulin (Long-Acting Insulin) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2029)
3.5.3 Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.6.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2029)
3.6.3 Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.7.1 Latin America Basal Insulin (Long-Acting Insulin) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2029)
3.7.3 Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.8.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2018-2029)
4.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2018-2023)
4.1.2 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2024-2029)
4.1.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2018-2029)
4.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2018-2029)
4.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2018-2023)
4.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2024-2029)
4.2.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2018-2029)
4.3 Global Basal Insulin (Long-Acting Insulin) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2018-2029)
5.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2018-2023)
5.1.2 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2029)
5.1.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2018-2029)
5.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2018-2029)
5.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2018-2023)
5.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2024-2029)
5.2.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2018-2029)
5.3 Global Basal Insulin (Long-Acting Insulin) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi Aventis
6.2.1 Sanofi Aventis Corporation Information
6.2.2 Sanofi Aventis Description and Business Overview
6.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Portfolio
6.2.5 Sanofi Aventis Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Biocon
6.4.1 Biocon Corporation Information
6.4.2 Biocon Description and Business Overview
6.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biocon Basal Insulin (Long-Acting Insulin) Product Portfolio
6.4.5 Biocon Recent Developments/Updates
6.5 Julphar
6.5.1 Julphar Corporation Information
6.5.2 Julphar Description and Business Overview
6.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Julphar Basal Insulin (Long-Acting Insulin) Product Portfolio
6.5.5 Julphar Recent Developments/Updates
6.6 Exir
6.6.1 Exir Corporation Information
6.6.2 Exir Description and Business Overview
6.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Exir Basal Insulin (Long-Acting Insulin) Product Portfolio
6.6.5 Exir Recent Developments/Updates
6.7 Sedico
6.6.1 Sedico Corporation Information
6.6.2 Sedico Description and Business Overview
6.6.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sedico Basal Insulin (Long-Acting Insulin) Product Portfolio
6.7.5 Sedico Recent Developments/Updates
6.8 Wockhardt
6.8.1 Wockhardt Corporation Information
6.8.2 Wockhardt Description and Business Overview
6.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Wockhardt Basal Insulin (Long-Acting Insulin) Product Portfolio
6.8.5 Wockhardt Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Basal Insulin (Long-Acting Insulin) Industry Chain Analysis
7.2 Basal Insulin (Long-Acting Insulin) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Basal Insulin (Long-Acting Insulin) Production Mode & Process
7.4 Basal Insulin (Long-Acting Insulin) Sales and Marketing
7.4.1 Basal Insulin (Long-Acting Insulin) Sales Channels
7.4.2 Basal Insulin (Long-Acting Insulin) Distributors
7.5 Basal Insulin (Long-Acting Insulin) Customers
8 Basal Insulin (Long-Acting Insulin) Market Dynamics
8.1 Basal Insulin (Long-Acting Insulin) Industry Trends
8.2 Basal Insulin (Long-Acting Insulin) Market Drivers
8.3 Basal Insulin (Long-Acting Insulin) Market Challenges
8.4 Basal Insulin (Long-Acting Insulin) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Basal Insulin (Long-Acting Insulin) Market Competitive Situation by Manufacturers in 2022
Table 4. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Basal Insulin (Long-Acting Insulin) Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Basal Insulin (Long-Acting Insulin), Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Product Type & Application
Table 12. Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Basal Insulin (Long-Acting Insulin) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Basal Insulin (Long-Acting Insulin) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2018-2023) & (K Units)
Table 18. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2018-2023)
Table 19. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2024-2029) & (K Units)
Table 20. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2024-2029)
Table 21. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2018-2023)
Table 23. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2024-2029)
Table 25. North America Basal Insulin (Long-Acting Insulin) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2023) & (K Units)
Table 27. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2029) & (K Units)
Table 28. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2023) & (K Units)
Table 32. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2029) & (K Units)
Table 33. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2018-2023)
Table 51. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2024-2029)
Table 52. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2018-2023)
Table 53. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2024-2029)
Table 54. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2018-2023)
Table 57. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2024-2029)
Table 58. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2018-2023)
Table 59. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2024-2029)
Table 60. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Application (2018-2023)
Table 61. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Application (2024-2029)
Table 62. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2018-2023)
Table 63. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2024-2029)
Table 64. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2018-2023)
Table 67. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2024-2029)
Table 68. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2018-2023)
Table 69. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2024-2029)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Aventis Corporation Information
Table 76. Sanofi Aventis Description and Business Overview
Table 77. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product
Table 79. Sanofi Aventis Recent Developments/Updates
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Eli Lilly Basal Insulin (Long-Acting Insulin) Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Biocon Corporation Information
Table 86. Biocon Description and Business Overview
Table 87. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Biocon Basal Insulin (Long-Acting Insulin) Product
Table 89. Biocon Recent Developments/Updates
Table 90. Julphar Corporation Information
Table 91. Julphar Description and Business Overview
Table 92. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Julphar Basal Insulin (Long-Acting Insulin) Product
Table 94. Julphar Recent Developments/Updates
Table 95. Exir Corporation Information
Table 96. Exir Description and Business Overview
Table 97. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Exir Basal Insulin (Long-Acting Insulin) Product
Table 99. Exir Recent Developments/Updates
Table 100. Sedico Corporation Information
Table 101. Sedico Description and Business Overview
Table 102. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Sedico Basal Insulin (Long-Acting Insulin) Product
Table 104. Sedico Recent Developments/Updates
Table 105. Wockhardt Corporation Information
Table 106. Wockhardt Description and Business Overview
Table 107. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Wockhardt Basal Insulin (Long-Acting Insulin) Product
Table 109. Wockhardt Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Basal Insulin (Long-Acting Insulin) Distributors List
Table 113. Basal Insulin (Long-Acting Insulin) Customers List
Table 114. Basal Insulin (Long-Acting Insulin) Market Trends
Table 115. Basal Insulin (Long-Acting Insulin) Market Drivers
Table 116. Basal Insulin (Long-Acting Insulin) Market Challenges
Table 117. Basal Insulin (Long-Acting Insulin) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Basal Insulin (Long-Acting Insulin)
Figure 2. Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Basal Insulin (Long-Acting Insulin) Market Share by Type in 2022 & 2029
Figure 4. Lantus Product Picture
Figure 5. Levemir Product Picture
Figure 6. Tresiba Product Picture
Figure 7. Toujeo Product Picture
Figure 8. Basaglar Product Picture
Figure 9. Biosimilar Glargines Product Picture
Figure 10. Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Basal Insulin (Long-Acting Insulin) Market Share by Application in 2022 & 2029
Figure 12. Type 1 Diabetes
Figure 13. Type 2 Diabetes
Figure 14. Global Basal Insulin (Long-Acting Insulin) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Basal Insulin (Long-Acting Insulin) Market Size (2018-2029) & (US$ Million)
Figure 16. Global Basal Insulin (Long-Acting Insulin) Sales (2018-2029) & (K Units)
Figure 17. Global Basal Insulin (Long-Acting Insulin) Average Price (US$/Unit) & (2018-2029)
Figure 18. Basal Insulin (Long-Acting Insulin) Report Years Considered
Figure 19. Basal Insulin (Long-Acting Insulin) Sales Share by Manufacturers in 2022
Figure 20. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Basal Insulin (Long-Acting Insulin) Players: Market Share by Revenue in 2022
Figure 22. Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Basal Insulin (Long-Acting Insulin) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2018-2029)
Figure 25. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2018-2029)
Figure 26. United States Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2018-2029)
Figure 29. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2018-2029)
Figure 30. Germany Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2018-2029)
Figure 37. China Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2018-2029)
Figure 47. Latin America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Basal Insulin (Long-Acting Insulin) by Type (2018-2029)
Figure 57. Global Revenue Market Share of Basal Insulin (Long-Acting Insulin) by Type (2018-2029)
Figure 58. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Basal Insulin (Long-Acting Insulin) by Application (2018-2029)
Figure 60. Global Revenue Market Share of Basal Insulin (Long-Acting Insulin) by Application (2018-2029)
Figure 61. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2018-2029)
Figure 62. Basal Insulin (Long-Acting Insulin) Value Chain
Figure 63. Basal Insulin (Long-Acting Insulin) Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs